Search

Turning the Tide on MS: Prodrome and Prevention Organized by the VA MSCoE

2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This clinical course will present the current understanding of the MS prodrome. The MS prodrome will be contrasted with other neurological conditions. The diagnosis of the radiologically isolated syndrome and clinical management will be highlighted. Using data from population-based studies, risk factors for MS …

Bugs and Drugs: Practical Management Considerations Around Infections and MS Disease Modifying Therapies

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …

Integrating Wearables into MS Clinical Care: From Research to Routine Practice

2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Wearables have evolved from research-based instruments into commercially-available sensors that continuously capture real-world function and lived experiences. In multiple sclerosis (MS), accelerometry and ecological momentary assessments (EMAs) captured by wearables provide reliable indicators of health, activity, and sleep/wake patterns, holding strong …

Emerging Cell-based Therapies in Multiple Sclerosis

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Nature continues to show that our own body can produce cells that can modify and treat a variety of conditions, including autoimmune diseases like MS. Technology allows for the isolation, purification and modification of cells to exploit their various properties. In this session …

Era of Too Many Choices; Starting and Switching

2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE There has been an explosion of new MS disease modifying therapies over the last decade. These therapies offer people with MS many treatment options including different routes of administration and mechanisms of action. With so many treatment options, selecting the right therapy for …

Responding to the Needs of Individuals with Advanced MS: Integrated Approaches to Care, Function, and Quality of Life

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE People living with advanced multiple sclerosis (MS) experience increasing disability, complex symptom burden, and heightened risk of fragmentation or disengagement from care at a time when coordinated support is essential. With the field’s emphasis on disease modification and disability …

Botulinum Toxin Injections for Migraine and Spasticity in Multiple Sclerosis: A Hands-On Training Symposium

2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This hands-on workshop is designed to transition participants from theoretical knowledge to clinical application, covering both upper and lower extremities. • Didactic Sessions: Participants will learn the mechanisms of action, therapeutic indications for MS-related spasticity, goal setting (e.g., using Goal Attainment Scaling), and patient …

Great Debate in MS Nursing: Are Digital Tools Enhancing or Eroding Patient Relationships?

2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE Digital health tools are rapidly reshaping how multiple sclerosis (MS) care is delivered. Telehealth visits, remote monitoring platforms, electronic patient-reported outcomes, and mobile apps now play a central role in how MS nurses, advanced practice providers, and PAs connect with patients. While these tools …

The June Halper Memorial Lecture: The Journey is the Destination: 40 Years of CMSC, 40 Years of MS Neuropsychiatry

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …

Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 1

2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …